Hoth Therapeutics, Inc. — Director's Dealing 2019

Mar 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-02-20

Reporting Person: Poor Kevin Jess (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-20	Common Stock	C	750000	—	Acquired	750000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-20	Series A Convertible Preferred Stock	$	C	750000	Disposed		Common Stock (750000)	Direct

Footnotes

F1: Shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock at a 1-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Articles of Incorporation, as amended).